These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35038612)

  • 21. Tranexamic acid for reduction of blood loss after Caesarean delivery: a cost-effectiveness analysis of the TRAAP2 trial.
    Sentilhes L; Bénard A; Madar H; Froeliger A; Petit S; Deneux-Tharaux C;
    Br J Anaesth; 2023 Nov; 131(5):893-900. PubMed ID: 37690946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial.
    Shakur H; Elbourne D; Gülmezoglu M; Alfirevic Z; Ronsmans C; Allen E; Roberts I
    Trials; 2010 Apr; 11():40. PubMed ID: 20398351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic use of tranexamic acid after vaginal delivery reduces the risk of primary postpartum hemorrhage.
    Saccone G; Della Corte L; D'Alessandro P; Ardino B; Carbone L; Raffone A; Guida M; Locci M; Zullo F; Berghella V
    J Matern Fetal Neonatal Med; 2020 Oct; 33(19):3368-3376. PubMed ID: 30704334
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of prophylactic intravenous tranexamic acid on blood loss after vaginal delivery in women at low risk of postpartum haemorrhage: a double-blind randomised controlled trial.
    Mirghafourvand M; Mohammad-Alizadeh S; Abbasalizadeh F; Shirdel M
    Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):53-8. PubMed ID: 25688820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic Tranexamic Acid in High-Risk Patients Undergoing Cesarean Delivery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Stortroen NE; Tubog TD; Shaffer SK
    AANA J; 2020 Aug; 88(4):273-281. PubMed ID: 32718424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized placebo-controlled trial of preoperative tranexamic acid among women undergoing elective cesarean delivery.
    Maged AM; Helal OM; Elsherbini MM; Eid MM; Elkomy RO; Dahab S; Elsissy MH
    Int J Gynaecol Obstet; 2015 Dec; 131(3):265-8. PubMed ID: 26341174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial.
    Ducloy-Bouthors AS; Jeanpierre E; Saidi I; Baptiste AS; Simon E; Lannoy D; Duhamel A; Allorge D; Susen S; Hennart B
    Trials; 2018 Mar; 19(1):149. PubMed ID: 29490690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tranexamic acid, as an adjunct to oxytocin prophylaxis, in the prevention of postpartum haemorrhage in women undergoing elective caesarean section: A single-centre double-blind randomised controlled trial.
    Lee SH; Kwek ME; Tagore S; Wright A; Ku CW; Teong ACA; Tan AWM; Lim SWC; Yen DYT; Ang CYX; Sultana R; Lim CHF; Mathur D; Mathur M
    BJOG; 2023 Aug; 130(9):1007-1015. PubMed ID: 36852501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic tranexamic acid in Cesarean delivery: an updated meta-analysis with a trial sequential analysis.
    Provinciatto H; Barbalho ME; da Câmara PM; Donadon IB; Fonseca LM; Bertani MS; Marinho AD; Sirena E; Provinciatto A; Amaral S
    Can J Anaesth; 2024 Apr; 71(4):465-478. PubMed ID: 38453797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tranexamic acid dose-response relationship for antifibrinolysis in postpartum haemorrhage during Caesarean delivery: TRACES, a double-blind, placebo-controlled, multicentre, dose-ranging biomarker study.
    Ducloy-Bouthors AS; Gilliot S; Kyheng M; Faraoni D; Turbelin A; Keita-Meyer H; Rigouzzo A; Moyanotidou G; Constant B; Broisin F; Gouez AL; Favier R; Peynaud E; Ghesquiere L; Lebuffe G; Duhamel A; Allorge D; Susen S; Hennart B; Jeanpierre E; Odou P;
    Br J Anaesth; 2022 Dec; 129(6):937-945. PubMed ID: 36243576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic Use of Tranexamic Acid for Postpartum Bleeding Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Alam A; Choi S
    Transfus Med Rev; 2015 Oct; 29(4):231-41. PubMed ID: 26282735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial.
    Xu J; Gao W; Ju Y
    Arch Gynecol Obstet; 2013 Mar; 287(3):463-8. PubMed ID: 23064441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study.
    Gungorduk K; Yıldırım G; Asıcıoğlu O; Gungorduk OC; Sudolmus S; Ark C
    Am J Perinatol; 2011 Mar; 28(3):233-40. PubMed ID: 20979013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraoperative tranexamic acid to decrease blood loss during myomectomy: a randomized, double-blind, placebo-controlled trial.
    Opoku-Anane J; Vargas MV; Marfori CQ; Moawad G; Maasen MS; Robinson JK
    Am J Obstet Gynecol; 2020 Sep; 223(3):413.e1-413.e7. PubMed ID: 32229194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the efficacy of prophylactic tranexamic acid in preventing postpartum bleeding: systematic review with meta-analysis of randomized clinical trials.
    Assis IC; Govêia CS; Miranda DB; Ferreira RS; Riccio LGC
    Braz J Anesthesiol; 2023; 73(4):467-476. PubMed ID: 35995323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial.
    Topsoee MF; Bergholt T; Ravn P; Schouenborg L; Moeller C; Ottesen B; Settnes A
    Am J Obstet Gynecol; 2016 Jul; 215(1):72.e1-8. PubMed ID: 26829509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tranexamic acid in the routine treatment of postpartum hemorrhage in the United States: a cost-effectiveness analysis.
    Sudhof LS; Shainker SA; Einerson BD
    Am J Obstet Gynecol; 2019 Sep; 221(3):275.e1-275.e12. PubMed ID: 31226298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tranexamic acid for preventing postpartum blood loss at cesarean delivery: is evidence sufficient?
    Sentilhes L; Brun S; Madar H; Deneux-Tharaux C
    Acta Obstet Gynecol Scand; 2016 Jul; 95(7):836. PubMed ID: 26866717
    [No Abstract]   [Full Text] [Related]  

  • 39. Pre-operative tranexemic acid vs. etamsylate in reducing blood loss during elective cesarean section: randomized controlled trial.
    Torky H; El-Desouky ES; Abo-Elmagd I; Mohamed A; Abdalhamid A; El-Shahat A; Ahmed Sileem S; Tawfick MM; Abo-Louz A; Hussein A
    J Perinat Med; 2021 Mar; 49(3):353-356. PubMed ID: 33064669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of preoperative tranexamic acid in reducing intraoperative and postoperative blood loss in high-risk women undergoing cesarean delivery: a randomized controlled trial.
    Shalaby MA; Maged AM; Al-Asmar A; El Mahy M; Al-Mohamady M; Rund NMA
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):201. PubMed ID: 35287618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.